Healthtech Startups

Curadite provides a secure and transparent packaging platform designed to serve customers and their users with accurate information and authentication.

1 investor

Curahealth is an owner-operated provider of inpatient long-term acute care (LTAC) and inpatient rehabilitation facility (IRF) hospitals in the United States. It operates facilities under the Curahealth Hospitals and Cobalt Rehabilitation names, serving patients needing extended acute and rehabilitative care.

1 investor

CuraLinc provides mental health and employee assistance services to employers, offering immediate clinical engagement through licensed therapists available within seconds, combined with a continuum of counseling, coaching, and digital support tools. The company serves enterprise clients seeking to reduce healthcare costs and improve employee wellbeing outcomes.

1 investor

Curapath is a European Contract Development and Manufacturing Organization (CDMO) specializing in polymer- and lipid-based non-viral drug delivery systems for biotech and pharmaceutical companies. The company develops and manufactures lipid nanoparticles, polymer nanoparticles, and delivery components from early development through GMP-certified commercial manufacturing for oncology, cell and gene therapy, and vaccine applications.

1 investor

CuraPatient builds healthcare software focused on the medical claims process, originating from its Othena platform used to schedule and deliver COVID-19 vaccinations in Orange County. The company now serves payers and providers at enterprise scale, including a top-5 U.S. integrated payer and a 46-hospital health system.

1 investor

Curatia Medical develops and manufactures FDA and CE-approved disposable medical devices for interventional procedures in cardiology, peripheral, neurology, and pulmonology. The company serves healthcare providers globally through its own brands and OEM manufacturing partnerships.

1 investor

Curative offers employer-sponsored health insurance with $0 copays, $0 deductibles, and a single monthly premium, aiming to remove cost barriers to care. The plan includes a nationwide provider network, telehealth, a Cash Card for out-of-pocket-free visits, an annual Baseline Visit, and care navigators.

1 investor

Curato matches Norwegian patients with private X-ray clinics for radiological services including MR, CT, and mammography. The platform aggregates pricing and quality information to help patients find affordable diagnostic imaging providers outside the public healthcare system.

1 investor

Cure Kids is a New Zealand charity that raises funds to support medical research into child health conditions such as preterm health, childhood cancers, rheumatic heart disease, and neurological disorders. It has funded over $70M of research across more than 700 projects, currently backing over 100 active projects led by researchers across Aotearoa.

1 investor

Curelink is an applied AI lab focused on chronic care, developing technology intended to make continuous, adaptive care widely accessible. It aims to address gaps in the current system for managing chronic disease.

1 investor

A telemedicine and diagnostic platform that enables patients to upload prescriptions and access lab tests across multiple Indian cities. The company connects patients with diagnostic services and tests through its mobile app and website.

1 investor

CureMatch provides a digital decision support system that guides oncologists in selecting personalized cancer drug treatments based on individual patients' molecular tumor profiles.

1 investor

CureMint provides a software platform that streamlines procurement for dental practices, replacing outdated systems to reduce overspending and operational inefficiencies. The company serves dental organizations across the United States with cloud-based procurement solutions.

1 investor

CUREOSITY develops CUREO, a virtual reality therapy system used in rehabilitation institutions to treat patients with motorsensory and cognitive impairments. The company serves clinics and practices, primarily in Germany but also globally, within the digital health and medtech sector.

1 investor

Curesign is a medical device company developing a system that combines sensors with signal processing and big data tools to help oncologists tailor patient-specific cancer treatments. Its technology has been demonstrated in preclinical studies and is being developed into a commercial product for oncology trials.

1 investor

Curesponse applies science and technology to improve cancer treatment, bringing together medical executives, scientists, and clinical and regulatory experts. The company operates laboratories in the UK and Israel to support oncology treatment decisions.

1 investor

Curestream develops an artificial pancreas system for diabetes management, combining an AI insulin control algorithm, modular insulin pump, and blood glucose management app to automate insulin delivery without user intervention.

1 investor

Cureus is an open-access medical journal platform that publishes peer-reviewed research. The platform uses technology and structured workflows to accelerate the peer review and publication process for medical research across all specialties.

1 investor

Curia provides R&D and manufacturing services to help clients address complex scientific and production challenges. The company employs over 3,000 scientists and specialists across 20 global locations.

1 investor

Curiato develops a smart surface monitoring system that uses the bed surface to continuously track patient pressure and humidity, generating clinical-grade data and insights. Its interoperable platform is designed for healthcare facilities to integrate with their data ecosystems and command centre applications.

1 investor

Curiflow provides a platform that extracts, validates, normalizes, and structures unstructured healthcare data from multiple sources within minutes. The platform serves healthcare organizations, insurers, and health technology vendors that need clean, organized patient data for eligibility assessment, claims audit, HCC coding, HEDIS reporting, and prior authorization.

1 investor

Curileum develops regenerative medicine therapies targeting intestinal stem cells to prevent colorectal cancer. The company works with specialist partners in chemistry and regulatory affairs to advance its clinical pipeline.

1 investor

Curio provides mental health care services focused on closing health equity gaps for women, leveraging a team with expertise in healthcare, regulatory affairs, and clinical research.

1 investor

Curiox Biosystems develops centrifuge-free, pipette-based cell washing technology that replaces manual centrifugation with software-defined flow executed on standard liquid handling platforms. Its tools serve research labs performing flow cytometry, immune monitoring, and cell preparation workflows in life sciences.

1 investor